{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:48:30Z","timestamp":1762098510467},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T00:00:00Z","timestamp":1441152000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00392-015-0907-3","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T07:57:06Z","timestamp":1441094226000},"page":"206-215","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial"],"prefix":"10.1007","volume":"105","author":[{"given":"Liefke C.","family":"van der Heijden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies M.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming Kai","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Danse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander R.","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian A. J.","family":"Jessurun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Melvyn","family":"Tjon Joe Gin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Gert","family":"van Houwelingen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond W. M.","family":"Hautvast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard C. M.","family":"Linssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanim","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marije M.","family":"L\u00f6wik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten J.","family":"IJzerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine J. M.","family":"Doggen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"von Birgelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"key":"907_CR1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4244\/EIJV10I5A97","volume":"10","author":"JF Lassen","year":"2014","unstructured":"Lassen JF, Holm NR, Stankovic G et al (2014) Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10\u00a0years of the European Bifurcation Club meetings. EuroIntervention 10:545\u2013560","journal-title":"EuroIntervention"},{"key":"907_CR2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.recesp.2014.05.005","volume":"67","author":"C Birgelen von","year":"2014","unstructured":"von Birgelen C, van Houwelingen KG, Lam MK (2014) Coronary bifurcations: still the touchstone of drug-eluting stents and bioresorbable vascular scaffolds? Rev Esp Cardiol 67:797\u2013803","journal-title":"Rev Esp Cardiol"},{"key":"907_CR3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/01.CIR.0000118474.71662.E3","volume":"109","author":"A Colombo","year":"2004","unstructured":"Colombo A, Moses JW, Morice MC et al (2004) Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 109:1244\u20131249","journal-title":"Circulation"},{"key":"907_CR4","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.ahj.2006.06.035","volume":"152","author":"L Thuesen","year":"2006","unstructured":"Thuesen L, Kelbaek H, Klovgaard L et al (2006) Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress\/Benestent Disease Trial (SCANDSTENT). Am Heart J 152:1140\u20131145","journal-title":"Am Heart J"},{"key":"907_CR5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2143\/AC.64.5.2042686","volume":"64","author":"F Colombo","year":"2009","unstructured":"Colombo F, Biondi-Zoccai G, Infantino V et al (2009) A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions. Acta Cardiol 64:583\u2013588","journal-title":"Acta Cardiol"},{"key":"907_CR6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ahj.2010.06.028","volume":"160","author":"E Romagnoli","year":"2010","unstructured":"Romagnoli E, De Servi S, Tamburino C et al (2010) Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS). Am Heart J 160:535\u2013542","journal-title":"Am Heart J"},{"key":"907_CR7","first-page":"50","volume":"23","author":"A Tommasino","year":"2011","unstructured":"Tommasino A, Burzotta F, Sciahbasi A et al (2011) Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry. J Invasive Cardiol 23:50\u201354","journal-title":"J Invasive Cardiol"},{"key":"907_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.carrev.2013.09.006","volume":"14","author":"C Costopoulos","year":"2013","unstructured":"Costopoulos C, Latib A, Ferrarello S et al (2013) First versus second-generation drug-eluting stents for the treatment of coronary bifurcations. Cardiovasc Revasc Med 14:311\u2013315","journal-title":"Cardiovasc Revasc Med"},{"key":"907_CR9","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jacc.2012.01.008","volume":"59","author":"C Birgelen von","year":"2012","unstructured":"von Birgelen C, Basalus MW, Tandjung K et al (2012) A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial. J Am Coll Cardiol 59:1350\u20131361","journal-title":"J Am Coll Cardiol"},{"key":"907_CR10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","volume":"375","author":"E Kedhi","year":"2010","unstructured":"Kedhi E, Joesoef KS, McFadden E et al (2010) Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet 375:201\u2013209","journal-title":"Lancet"},{"key":"907_CR11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","volume":"363","author":"PW Serruys","year":"2010","unstructured":"Serruys PW, Silber S, Garg S et al (2010) Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med 363:136\u2013146","journal-title":"N Engl J Med"},{"key":"907_CR12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00392-013-0546-5","volume":"102","author":"I Akin","year":"2013","unstructured":"Akin I, Hochadel M, Abdel-Wahab M et al (2013) Clinical outcomes of different first- and second-generation drug-eluting stents in routine clinical practice: results from the prospective multicenter German DES.DE registry. Clin Res Cardiol 102:371\u2013381","journal-title":"Clin Res Cardiol"},{"key":"907_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00392-011-0359-3","volume":"101","author":"J W\u00f6hrle","year":"2012","unstructured":"W\u00f6hrle J, Rottbauer W, Imhof A (2012) Everolimus-eluting stents for treatment of chronic total coronary occlusions. Clin Res Cardiol 101:23\u201328","journal-title":"Clin Res Cardiol"},{"key":"907_CR14","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jacc.2013.07.044","volume":"62","author":"J Mehilli","year":"2013","unstructured":"Mehilli J, Richardt G, Valgimigli M et al (2013) Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 62:2075\u20132082","journal-title":"J Am Coll Cardiol"},{"key":"907_CR15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00392-012-0490-9","volume":"101","author":"G Ndrepepa","year":"2012","unstructured":"Ndrepepa G, Tada T, Fusaro M et al (2012) Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol 101:1003\u20131011","journal-title":"Clin Res Cardiol"},{"key":"907_CR16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00392-013-0582-1","volume":"102","author":"I Akin","year":"2013","unstructured":"Akin I, Naber C, Sabin G et al (2013) Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry. Clin Res Cardiol 102:679\u2013686","journal-title":"Clin Res Cardiol"},{"key":"907_CR17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijcard.2014.08.036","volume":"176","author":"H Sen","year":"2014","unstructured":"Sen H, Lam MK, Tandjung K et al (2014) Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and Non-Enrolled TWENTE registry. Int J Cardiol 176:885\u2013890","journal-title":"Int J Cardiol"},{"key":"907_CR18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00392-014-0662-x","volume":"103","author":"I Akin","year":"2014","unstructured":"Akin I, Nienaber CA, Richardt G et al (2014) Risk factors for clinical events at 1-year follow-up after drug-eluting stent implantation: results from the perspective multicenter German DES.DE registry. Clin Res Cardiol 103:363\u2013372","journal-title":"Clin Res Cardiol"},{"key":"907_CR19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.recesp.2013.10.018","volume":"67","author":"M Pan","year":"2014","unstructured":"Pan M, Burzotta F, Trani C et al (2014) Three-year follow-up of patients with bifurcation lesions treated with sirolimus- or everolimus-eluting stents: SEAside and CORpal cooperative study. Rev Esp Cardiol 67:797\u2013803","journal-title":"Rev Esp Cardiol"},{"key":"907_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ahj.2014.10.011","volume":"169","author":"MK Lam","year":"2015","unstructured":"Lam MK, Sen H, van Houwelingen KG et al (2015) Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial. Am Heart J 169:69\u201377","journal-title":"Am Heart J"},{"key":"907_CR21","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/heartjnl-2013-303778","volume":"99","author":"R Diletti","year":"2013","unstructured":"Diletti R, Garcia-Garcia HM, Bourantas CV et al (2013) Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial. Heart 99:1267\u20131274","journal-title":"Heart"},{"key":"907_CR22","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jcin.2011.11.002","volume":"4","author":"JA Ormiston","year":"2011","unstructured":"Ormiston JA, Webber B, Webster MW (2011) Stent longitudinal integrity bench insights into a clinical problem. J Am Coll Cardiol Interv 4:1310\u20131317","journal-title":"J Am Coll Cardiol Interv"},{"key":"907_CR23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4244\/EIJV10I1A19","volume":"10","author":"F Burzotta","year":"2014","unstructured":"Burzotta F, Mortier P, Trani C (2014) Characteristics of drug-eluting stent platforms potentially influencing bifurcated lesion provisional stenting procedure. EuroIntervention 10:124\u2013132","journal-title":"EuroIntervention"},{"key":"907_CR24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(13)62037-1","volume":"383","author":"C Birgelen von","year":"2014","unstructured":"von Birgelen C, Sen H, Lam MK et al (2014) Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial. Lancet 383:413\u2013423","journal-title":"Lancet"},{"key":"907_CR25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jcin.2015.01.033","volume":"8","author":"H Sen","year":"2015","unstructured":"Sen H, Lam MK, L\u00f6wik MM et al (2015) Clinical events and patient-reported chest pain in all-comers treated with resolute integrity and promus element stents: two-year follow-up of the randomized DUTCH PEERS (TWENTE II) trial. J Am Coll Cardiol Interv 8:889\u2013899","journal-title":"J Am Coll Cardiol Interv"},{"key":"907_CR26","first-page":"219","volume":"1","author":"S Sianos","year":"2005","unstructured":"Sianos S, Morel MA, Kappetein AP et al (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219\u2013227","journal-title":"EuroIntervention"},{"key":"907_CR27","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R et al (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344\u20132351","journal-title":"Circulation"},{"key":"907_CR28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4244\/EIJV5I7A146","volume":"5","author":"P Vranckx","year":"2010","unstructured":"Vranckx P, Cutlip DE, Mehran R et al (2010) Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies. EuroIntervention 5:871\u2013874","journal-title":"EuroIntervention"},{"key":"907_CR29","first-page":"630","volume":"26","author":"M Ferenc","year":"2014","unstructured":"Ferenc M, Kornowski R, Belardi J et al (2014) Three-year outcomes of percutaneous coronary intervention with next-generation zotarolimus-eluting stents for de novo coronary bifurcation lesions. J Invasive Cardiol 26:630\u2013638","journal-title":"J Invasive Cardiol"},{"key":"907_CR30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.amjcard.2013.12.016","volume":"113","author":"DW Park","year":"2004","unstructured":"Park DW, Kim YH, Yun SC et al (2004) Impact of the angiographic mechanisms underlying periprocedural myocardial infarction after drug-eluting stent implantation. Am J Cardiol 113:1105\u20131110","journal-title":"Am J Cardiol"},{"key":"907_CR31","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.ijcard.2012.09.005","volume":"167","author":"S Roversi","year":"2013","unstructured":"Roversi S, Biondi-Zoccai G, Romagnoli E et al (2013) Early and long-term outlook of percutaneous coronary intervention for bifurcation lesions in young patients. Int J Cardiol 167:2995\u20132999","journal-title":"Int J Cardiol"},{"key":"907_CR32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCULATIONAHA.110.966879","volume":"123","author":"M Niemel\u00e4","year":"2011","unstructured":"Niemel\u00e4 M, Kervinen K, Erglis A et al (2011) Randomized comparison of final kissing balloon dilatation versus no final kissing balloon dilatation in patients with coronary bifurcation lesions treated with main vessel stenting: the Nordic-Baltic Bifurcation Study III. Circulation 123:79\u201386","journal-title":"Circulation"},{"key":"907_CR33","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1253\/circj.CJ-12-0848","volume":"77","author":"H Hariki","year":"2013","unstructured":"Hariki H, Shinke T, Otake H et al (2013) Potential benefit of final kissing balloon inflation after single stenting for the treatment of bifurcation lesions\u2014insights from optical coherence tomography observations. Circ J 77:1193\u20131201","journal-title":"Circ J"},{"key":"907_CR34","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ijcard.2014.10.029","volume":"177","author":"TH Kim","year":"2014","unstructured":"Kim TH, Lee HJ, Jang H et al (2014) Impact of final kissing balloon inflation after simple stent implantation for the treatment of non-left main true coronary bifurcation lesions in patients with acute coronary syndrome. Int J Cardiol 177:907\u2013911","journal-title":"Int J Cardiol"},{"key":"907_CR35","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/CIRCULATIONAHA.109.888297","volume":"121","author":"D Hildick-Smith","year":"2010","unstructured":"Hildick-Smith D, de Belder AJ, Cooter N et al (2010) Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new and evolving strategies. Circulation 121:1235\u20131243","journal-title":"Circulation"},{"key":"907_CR36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00392-014-0671-9","volume":"103","author":"A Schulz","year":"2014","unstructured":"Schulz A, Hauschild T, Kleber FX et al (2014) Treatment of coronary de novo bifurcation lesions with DCB only strategy. Clin Res Cardiol 103:451\u2013456","journal-title":"Clin Res Cardiol"},{"key":"907_CR37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijcard.2014.03.029","volume":"174","author":"NI Kherada","year":"2014","unstructured":"Kherada NI, Sartori S, Tomey MI et al (2014) Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation study. Int J Cardiol 174:13\u201317","journal-title":"Int J Cardiol"},{"key":"907_CR38","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.ijcard.2012.03.146","volume":"167","author":"PS Song","year":"2013","unstructured":"Song PS, Song YB, Yang JH et al (2013) Periprocedural myocardial infarction is not associated with an increased risk of long-term cardiac mortality after coronary bifurcation stenting. Int J Cardiol 167:1251\u20131256","journal-title":"Int J Cardiol"},{"key":"907_CR39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2008.10.016","volume":"139","author":"G Niccoli","year":"2015","unstructured":"Niccoli G, Ferrante G, Porto I et al (2015) Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents. Int J Cardiol 139:80\u201391","journal-title":"Int J Cardiol"},{"key":"907_CR40","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.jacc.2013.07.041","volume":"62","author":"JY Hahn","year":"2013","unstructured":"Hahn JY, Chun WJ, Kim JH et al (2013) Predictors and outcomes of side branch occlusion after main vessel stenting in coronary bifurcation lesions: results from the COBIS II Registry (COronary BIfurcation Stenting. J Am Coll Cardiol 62:1654\u20131659","journal-title":"J Am Coll Cardiol"},{"key":"907_CR41","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ijcard.2012.09.130","volume":"168","author":"X Freixa","year":"2013","unstructured":"Freixa X, Almasood AA, Asif N et al (2013) Long-term outcomes using a two-stent technique for the treatment of coronary bifurcations. Int J Cardiol 168:446\u2013451","journal-title":"Int J Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-015-0907-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-015-0907-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-015-0907-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:14:18Z","timestamp":1551208458000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-015-0907-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["907"],"URL":"https:\/\/doi.org\/10.1007\/s00392-015-0907-3","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}